Mitsubishi UFJ Asset Management Co., Ltd. - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 80 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management Co., Ltd. ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$153,000
-45.6%
74,256
+7.4%
0.00%0.0%
Q4 2021$281,000
-10.8%
69,140
+13.6%
0.00%
-50.0%
Q3 2021$315,000
+21.6%
60,8480.0%0.00%
+100.0%
Q2 2021$259,000
-36.5%
60,848
-20.9%
0.00%
-66.7%
Q1 2021$408,000
+48.9%
76,920
+51.1%
0.00%
+50.0%
Q4 2020$274,000
+122.8%
50,907
+77.9%
0.00%
-33.3%
Q1 2019$123,000
-12.8%
28,621
+8.7%
0.00%
-25.0%
Q4 2018$141,000
-5.4%
26,341
+139.9%
0.00%
+33.3%
Q3 2018$149,00010,9800.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 15,832,611$68,080,0003.54%
Matrix Capital Management Company, LP 28,000,000$120,400,0003.21%
Virtus ETF Advisers LLC 50,655$218,0000.46%
TFG Asset Management GP Ltd 500,000$2,150,0000.27%
Rock Springs Capital Management LP 800,000$3,440,0000.13%
Orbimed Advisors 1,350,655$5,808,0000.09%
Vident Investment Advisory, LLC 289,340$1,244,0000.07%
WS MANAGEMENT LLLP 185,537$798,0000.05%
Rathbones Group PLC 285,722$1,229,0000.04%
Tekla Capital Management LLC 228,496$983,0000.04%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders